Galapagos NV
GLPG
#4956
Rank
โ‚น178.18 B
Marketcap
โ‚น2,653
Share price
0.00%
Change (1 day)
8.20%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: โ‚น178.18 Billion

As of May 2026 Galapagos NV has a market cap of โ‚น178.18 Billion. This makes Galapagos NV the world's 4956th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น178.18 B-8.8%
2025โ‚น195.39 B26.61%
2024โ‚น154.32 B-30.79%
2023โ‚น223.00 B-7.77%
2022โ‚น241.77 B-11.08%
2021โ‚น271.90 B-42.58%
2020โ‚น473.53 B-50.85%
2019โ‚น963.38 B174.51%
2018โ‚น350.95 B14.45%
2017โ‚น306.65 B51.43%
2016โ‚น202.50 B23.62%
2015โ‚น163.81 B352.89%
2014โ‚น36.17 B-6.59%
2013โ‚น38.72 B25.14%
2012โ‚น30.94 B63.99%
2011โ‚น18.86 B-1.02%
2010โ‚น19.06 B61.18%
2009โ‚น11.82 B139.45%
2008โ‚น4.93 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น53.973 T 30,190.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น14.567 T 8,075.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น36.463 T 20,363.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น10.128 T 5,583.91%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น28.927 T 16,134.05%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น27.752 T 15,474.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น9.864 T 5,436.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
โ‚น8.70 B-95.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น3.795 T 2,030.24%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel